Comparison of Different Promoter Methylation Assays in Breast Cancer

Background: Promoter hypermethylation has emerged as a promising cancer biomarker. Currently, a large variety of quantitative and non-quantitative techniques is used to measure methylation in clinical specimens. Here we directly compared three commonly used methylation assays and assessed the influe...

Full description

Saved in:
Bibliographic Details
Main Authors: Karijn P. M. Suijkerbuijk, Xiaojuan Pan, Elsken van der Wall, Paul J. van Diest, Marc Vooijs
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.3233/ACP-CLO-2010-0542
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567713334034432
author Karijn P. M. Suijkerbuijk
Xiaojuan Pan
Elsken van der Wall
Paul J. van Diest
Marc Vooijs
author_facet Karijn P. M. Suijkerbuijk
Xiaojuan Pan
Elsken van der Wall
Paul J. van Diest
Marc Vooijs
author_sort Karijn P. M. Suijkerbuijk
collection DOAJ
description Background: Promoter hypermethylation has emerged as a promising cancer biomarker. Currently, a large variety of quantitative and non-quantitative techniques is used to measure methylation in clinical specimens. Here we directly compared three commonly used methylation assays and assessed the influence of tissue fixation, target sequence location and the amount of DNA on their performance.
format Article
id doaj-art-2c986b62a5ae4cf38fb49051f98060e5
institution Kabale University
issn 2210-7177
2210-7185
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-2c986b62a5ae4cf38fb49051f98060e52025-02-03T01:00:40ZengWileyAnalytical Cellular Pathology2210-71772210-71852010-01-01333-413314110.3233/ACP-CLO-2010-0542Comparison of Different Promoter Methylation Assays in Breast CancerKarijn P. M. Suijkerbuijk0Xiaojuan Pan1Elsken van der Wall2Paul J. van Diest3Marc Vooijs4Department of Pathology, University Medical Center Utrecht Cancer Center, Utrecht, The NetherlandsDepartment of Pathology, University Medical Center Utrecht Cancer Center, Utrecht, The NetherlandsDepartment of Radiation Oncology (Maastro Lab), GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The NetherlandsDepartment of Pathology, University Medical Center Utrecht Cancer Center, Utrecht, The NetherlandsDepartment of Pathology, University Medical Center Utrecht Cancer Center, Utrecht, The NetherlandsBackground: Promoter hypermethylation has emerged as a promising cancer biomarker. Currently, a large variety of quantitative and non-quantitative techniques is used to measure methylation in clinical specimens. Here we directly compared three commonly used methylation assays and assessed the influence of tissue fixation, target sequence location and the amount of DNA on their performance.http://dx.doi.org/10.3233/ACP-CLO-2010-0542
spellingShingle Karijn P. M. Suijkerbuijk
Xiaojuan Pan
Elsken van der Wall
Paul J. van Diest
Marc Vooijs
Comparison of Different Promoter Methylation Assays in Breast Cancer
Analytical Cellular Pathology
title Comparison of Different Promoter Methylation Assays in Breast Cancer
title_full Comparison of Different Promoter Methylation Assays in Breast Cancer
title_fullStr Comparison of Different Promoter Methylation Assays in Breast Cancer
title_full_unstemmed Comparison of Different Promoter Methylation Assays in Breast Cancer
title_short Comparison of Different Promoter Methylation Assays in Breast Cancer
title_sort comparison of different promoter methylation assays in breast cancer
url http://dx.doi.org/10.3233/ACP-CLO-2010-0542
work_keys_str_mv AT karijnpmsuijkerbuijk comparisonofdifferentpromotermethylationassaysinbreastcancer
AT xiaojuanpan comparisonofdifferentpromotermethylationassaysinbreastcancer
AT elskenvanderwall comparisonofdifferentpromotermethylationassaysinbreastcancer
AT pauljvandiest comparisonofdifferentpromotermethylationassaysinbreastcancer
AT marcvooijs comparisonofdifferentpromotermethylationassaysinbreastcancer